<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJO</journal-id>
<journal-title-group>
<journal-title>International Journal of Oncology</journal-title></journal-title-group>
<issn pub-type="ppub">1019-6439</issn>
<issn pub-type="epub">1791-2423</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ijo.2016.3479</article-id>
<article-id pub-id-type="publisher-id">ijo-48-06-2453</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Oridonin induces apoptosis through the mitochondrial pathway in human gastric cancer SGC-7901 cells</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>GAO</surname><given-names>SHIYONG</given-names></name><xref rid="af1-ijo-48-06-2453" ref-type="aff">1</xref><xref rid="fn1-ijo-48-06-2453" ref-type="author-notes">*</xref><xref ref-type="corresp" rid="c1-ijo-48-06-2453"/></contrib>
<contrib contrib-type="author">
<name><surname>TAN</surname><given-names>HUIXIN</given-names></name><xref rid="af2-ijo-48-06-2453" ref-type="aff">2</xref><xref rid="fn1-ijo-48-06-2453" ref-type="author-notes">*</xref><xref ref-type="corresp" rid="c1-ijo-48-06-2453"/></contrib>
<contrib contrib-type="author">
<name><surname>ZHU</surname><given-names>NAN</given-names></name><xref rid="af3-ijo-48-06-2453" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author">
<name><surname>GAO</surname><given-names>HAIYU</given-names></name><xref rid="af1-ijo-48-06-2453" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>LV</surname><given-names>CHUNYU</given-names></name><xref rid="af1-ijo-48-06-2453" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>GANG</surname><given-names>JIAN</given-names></name><xref rid="af1-ijo-48-06-2453" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>JI</surname><given-names>YUBIN</given-names></name><xref rid="af1-ijo-48-06-2453" ref-type="aff">1</xref></contrib></contrib-group>
<aff id="af1-ijo-48-06-2453">
<label>1</label>The Institute of Materia Medica, The Research Center of Life Sciences and Environmental Sciences, Harbin University of Commerce, Harbin 150076, P.R. China</aff>
<aff id="af2-ijo-48-06-2453">
<label>2</label>Department of Pharmacy, The Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, P.R. China</aff>
<aff id="af3-ijo-48-06-2453">
<label>3</label>Engineering Research Center of Natural Anticancer Drugs of Ministry of Education, Harbin University of Commerce, Harbin 150076, P.R. China</aff>
<author-notes>
<corresp id="c1-ijo-48-06-2453">Correspondence to: Ms Huixin Tan, Department of Pharmacy, The Fourth Affiliated Hospital of Harbin Medical University, 37 Yiyuan Street, Nangang District, Harbin, Heilongjiang 150001, P.R. China, E-mail: <email>thxydsy@163.com</email>. Dr Shiyong Gao, The Institute of Materia Medica, The Research Center of Life Sciences and Environmental Sciences, Harbin University of Commerce, 138 Tongda Street, Daoli District, Harbin, Heilongjiang 150076, P.R. China, E-mail: <email>sygao2002@163.com</email></corresp><fn id="fn1-ijo-48-06-2453">
<label>*</label>
<p>Contributed equally</p></fn></author-notes>
<pub-date pub-type="collection">
<month>6</month>
<year>2016</year></pub-date>
<pub-date pub-type="epub">
<day>07</day>
<month>04</month>
<year>2016</year></pub-date>
<volume>48</volume>
<issue>6</issue>
<fpage>2453</fpage>
<lpage>2460</lpage>
<history>
<date date-type="received">
<day>11</day>
<month>02</month>
<year>2016</year></date>
<date date-type="accepted">
<day>21</day>
<month>03</month>
<year>2016</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2016, Spandidos Publications</copyright-statement>
<copyright-year>2016</copyright-year></permissions>
<abstract>
<p>Oridonin is one of the most important antitumor active ingredients of <italic>Rabdosia rubescens</italic>. Recently published studies from our laboratory have demonstrated that oridonin was able to arrest human gastric cancer SGC-7901 cells at G<sub>2</sub>/M phase. However, little is known about inducing apoptosis in gastric cancer. The aim of this study was to investigate the effect of oridonin on antineoplastic capability of SGC-7901 cells and the detailed molecular mechanism of oridonin-mediated intrinsic pathway of apoptosis. Cell proliferation was assessed by MTT assay while apoptosis induced by oridonin was determined by Hoechst 33342 staining assay and Annexin V/PI double staining assay. Early apoptotic rate was stained by Annexin V/PI and detected by flow cytometry. Apoptosis pathway was analyzed by western blot analysis of Bcl-2, Bax, cytochrome c and caspase-3 expression. The results showed that oridonin was able to inhibit the SGC-7901 cell proliferation, the 50&#x00025; growth inhibition (IC<sub>50</sub>) was 22.74 &#x003BC;M. Oridonin could induce cell apoptosis of SGC-7901 cells and the early apoptotic rates induced by 0, 20, 40, 80 &#x003BC;mol/l oridonin were 1.53&#x000B1;0.67, 3.33&#x000B1;0.29, 84.80&#x000B1;0.82 and 96.43&#x000B1;0.51&#x00025;, respectively. Western blot analysis revealed that oridonin downregulated Bcl-2 protein (the anti-apoptotic factor) and upregulated Bax protein (pro-apoptotic factor), eventually leading to a reduction in the ratio of Bcl-2/Bax proteins. Furthermore, oridonin induced the release of cytochrome c from the mitochondria to the cytosol and the activation of caspase-3. Taken together, the current study suggested that oridonin induced apoptosis in SGC-7901 cells via the mitochondrial signal pathway, which may represent one of the major mechanisms of oridonin-mediated apoptosis in SGC-7901 cells.</p></abstract>
<kwd-group>
<kwd>oridonin</kwd>
<kwd>apoptosis</kwd>
<kwd>mitochondrial pathway</kwd>
<kwd>human gastric cancer</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Gastric cancer is one of the most common malignant tumors worldwide. In less developed countries, stomach cancers are also leading causes of cancer death, which is generally about twice as high in men as in women (<xref rid="b1-ijo-48-06-2453" ref-type="bibr">1</xref>). The incidence and mortality rates vary widely across countries, the highest in high-income Asia Pacific, east Asia, and Andean Latin America (<xref rid="b2-ijo-48-06-2453" ref-type="bibr">2</xref>), which was related to dietary patterns, food storage, and the availability of fresh produce.</p>
<p>Chemotherapy is widely used in cancer treatment, it shows better therapy effect, but toxic and side effects cause serious harm to cancer patients. Recently, research interest has turned to the traditional medicine, and investigations of new anticancer drugs with low toxicity. <italic>Rabdosia rubescens</italic>, a medical plant, has been used to treat cancer in China for a long time (<xref rid="b3-ijo-48-06-2453" ref-type="bibr">3</xref>), and has been reported to show better effects in the treatment of urinary bladder carcinoma (<xref rid="b4-ijo-48-06-2453" ref-type="bibr">4</xref>), esophageal carcinoma (<xref rid="b5-ijo-48-06-2453" ref-type="bibr">5</xref>,<xref rid="b6-ijo-48-06-2453" ref-type="bibr">6</xref>), prostate cancer (<xref rid="b7-ijo-48-06-2453" ref-type="bibr">7</xref>), and oridonin is one of the most important antitumor active ingredient of <italic>Rabdosia rubescens</italic> (<xref rid="b8-ijo-48-06-2453" ref-type="bibr">8</xref>,<xref rid="b9-ijo-48-06-2453" ref-type="bibr">9</xref>).</p>
<p>Oridonin, molecular formula C<sub>20</sub>H<sub>28</sub>O<sub>6</sub> (<xref rid="f1-ijo-48-06-2453" ref-type="fig">Fig. 1</xref>), is a diterpenoid compound (<xref rid="b10-ijo-48-06-2453" ref-type="bibr">10</xref>). Previous studies have shown that oridonin has antitumor activities <italic>in vivo</italic> and <italic>in vitro</italic> (<xref rid="b11-ijo-48-06-2453" ref-type="bibr">11</xref>&#x02013;<xref rid="b13-ijo-48-06-2453" ref-type="bibr">13</xref>), and oridonin inhibited proliferation of cancer cells by inducing autophagic pathways (<xref rid="b14-ijo-48-06-2453" ref-type="bibr">14</xref>&#x02013;<xref rid="b18-ijo-48-06-2453" ref-type="bibr">18</xref>), arresting the cell cycle on G<sub>0</sub>/G<sub>1</sub> phase (<xref rid="b19-ijo-48-06-2453" ref-type="bibr">19</xref>) or G<sub>2</sub>/M phase (<xref rid="b20-ijo-48-06-2453" ref-type="bibr">20</xref>&#x02013;<xref rid="b24-ijo-48-06-2453" ref-type="bibr">24</xref>), inducing apoptosis of human laryngeal cancer cells (<xref rid="b25-ijo-48-06-2453" ref-type="bibr">25</xref>), esophageal cancer (<xref rid="b26-ijo-48-06-2453" ref-type="bibr">26</xref>), colorectal carcinoma (<xref rid="b27-ijo-48-06-2453" ref-type="bibr">27</xref>), pancreatic cancer (<xref rid="b28-ijo-48-06-2453" ref-type="bibr">28</xref>), hepatocellular carcinoma (<xref rid="b29-ijo-48-06-2453" ref-type="bibr">29</xref>,<xref rid="b30-ijo-48-06-2453" ref-type="bibr">30</xref>). However, few reports exist on oridonin-induced apoptosis on gastric cancer. Therefore, this study explored apoptosis and related protein expression induced by oridonin on human gastric cancer SGC-7901 cells.</p></sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title>Chemicals and other reagents</title>
<p>Oridonin (&gt;98&#x00025;) was purchased from National Institutes for Food and Drug Control (Beijing, China). Doxorubicin was obtained from Pharmacia Italia S.p.A., Gaggiano, Italy. Hydroxycamptothecin (HCPT) was provided by Shanghai Longxiang Biological Medicine Development Co. Ltd. (Shanghai, China). Dimethyl sulfoxide (DMSO), trypsin, Tris, glycine, acrylamide, methylene diacrylamide and Tween-20 were purchased from Sigma-Aldrich (St. Louis, MO, USA). RPMI-1640 cell culture medium was purchased from Gibco (Grand Island, NY, USA). Fetal calf serum (FCS) was purchased from Sijiqing Hangzhou Bio Engineering Co., Ltd. (Hangzhou, China). Hoechst33342, Annexin V-FITC apoptosis detection kit, DAB Horseradish Peroxidase Color Development kit were obtained from the Beyotime Institute of Biotechnology (Jiangsu, China). Antibodies for cytochrome c, Bcl-2, Bax, caspase-3, cleaved-caspase-3, &#x003B2;-actin, and the secondary antibodies were purchased from ZSGB-BIO (Beijing, China). All other chemicals and solvents used were the highest purity grade.</p></sec>
<sec>
<title>Cell line and culture conditions</title>
<p>The human gastric cancinoma SGC-7901 cell line was obtained from American Type Culture Collection (Manassas, VA, USA). The cells were cultured in RPMI-1640 supplement with 10&#x00025; (v/v) fetal bovine serum (FBS) and antibiotics (100 IU/ml of penicillin and 100 &#x003BC;g/ml of streptomycin) at 37&#x000B0;C in a humidified atmosphere containing 5&#x00025; CO<sub>2</sub>.</p></sec>
<sec>
<title>Cell viability and cytotoxicity</title>
<p>The cultured cells at the exponential growth phase were harvested from the culture flasks by trypsin and then re-suspended in fresh RPMI-1640 medium. The cell suspensions were dispensed into a 96-well microplate at 100 &#x003BC;l/well and placed in an incubator with 5&#x00025; CO<sub>2</sub> at 37&#x000B0;C. After 24 h, 100 &#x003BC;l various concentrations of oridonin were added and incubated for 72 h. Then the medium was discarded and 100 &#x003BC;l of MTT stock solution (1 mg/ml) was added. After incubation for 4 h, DMSO (150 &#x003BC;l) was added to each well to solubilize the water-insoluble purple formazan crystals. The amount of MTT-formazan is directly proportional to the number of living cells and was determined by measuring the optical density (OD) at 570 nm using microplate reader (model 680; Bio-Rad Laboratories, Hercules, CA, USA). The percentage of cytotoxic activity compared to the untreated cells was determined, and the IC<sub>50</sub> was calculated by the Logit method.</p></sec>
<sec>
<title>Cell nuclear morphology observation (Hoechst 33342)</title>
<p>Morphology of apoptotic cell was observed by Hoechst 33342 staining assay. The cells were washed in phosphate-buffered saline (PBS) and fixed in formaldehyde solution (4&#x00025;, w/v) for 30 min. Then the fixed cells were stained with 10 mg/ml Hoechst 33342 for 10 min, and nuclear morphology was observed under a fluorescence microscopy (Leica, Wetzlar, Germany) equipped with a digital camera.</p></sec>
<sec>
<title>Confocal laser scanning microscopy assay</title>
<p>Qualitative experiment of apoptosis was observed by confocal laser scanning microscopy after staining cells with the Annexin V-FITC apoptosis detection kit (MultiSciences Biotech Co., Ltd., Hangzhou, China). SGC-7901 cells (1.5&#x000D7;10<sup>5</sup> cells/well) were placed on 6-well plates and incubated with oridonin for 24 h. The cells were stained by Annexin V-FITC (green fluorescence) in the dark for phosphatidylserine (PS) examination. Then cells were stained with PI (red fluorescence) in the dark for nucleus examination. Stained cells were visualized by confocal laser scanning microscopy (Leica, SP2, Wetzlar, Germany) equipped with 488 nm Argon lasers (<xref rid="b31-ijo-48-06-2453" ref-type="bibr">31</xref>).</p></sec>
<sec>
<title>Flow cytometric analysis of apoptosis</title>
<p>Early apoptosis rate were measured using the Annexin V-FITC apoptosis detection kit (MultiSciences Biotech Co. Ltd., China) as described in the supplier instructions. After exposure to oridinin (0, 20, 40 and 80 &#x003BC;M) for 24 h, cells were harvested by centrifugation, washed twice with PBS, and resuspended in Binding Buffer, 5 &#x003BC;l of Annexin V-FITC and 5 &#x003BC;l of propidium iodide (PI, 50 mg/ml) was added and incubated at room temperature in the dark. The data acquisition and analysis were performed using MultiCycle software flow cytometry (Beckman Coulter, XL, USA).</p></sec>
<sec>
<title>Total protein extraction and western blot assay</title>
<p>SGC-7901 cells were treated with different concentration of oridonin. For isolation of total protein fractions, cells were collected, washed twice with cold PBS, and lysed with cell lysis buffer (50 mM Tris-Cl, pH 8.0, 120 mM NaCl, 50 mM NaF, 200 &#x003BC;M sodium vanadate, 0.5&#x00025; NP-40, 10 mM phenylmethylsulfonyl fluoride (PMSF), 2 &#x003BC;g/ml aprotinin 0.2 &#x003BC;l, 10 &#x003BC;g/ml leupeptin 10 &#x003BC;l). The lysates were centrifuged at 12000 &#x000D7; g for 10 min at 4&#x000B0;C, the supernatant was saved at &#x02212;20&#x000B0;C. Protein concentrations of cell lysates were detected by Bradford assay (<xref rid="b32-ijo-48-06-2453" ref-type="bibr">32</xref>). Total protein samples were separated by SDS-PAGE. The separated proteins were transferred to NC membranes. After being blocked with blocking solution (5&#x00025; skim milk in TBS, 10 mM Tris-HCl, 150 mM NaCl, pH 7.5 plus 0.1&#x00025; Tween-20) at room temperature for 2 h. Each membrane was incubated with primary antibodies overnight at 4&#x000B0;C. Afterwards, the membranes were probed with the appropriate horseradish-peroxidase conjugated secondary antibody for 2 h at room temperature. Detection was performed by the DAB Horseradish Peroxidase Color Development kit (Beyotime Institute of Biotechnology) according to the manufacturer's instructions. Bands were recorded and relative density units of the bands were analyzed by Gel Imaging System (Tanon, GIS-2019, Beijing, China). Densitometrical data of multiple experiments are shown.</p></sec>
<sec>
<title>Statistical analysis</title>
<p>The data are presented as the mean &#x000B1; SD. Statistical significance was calculated using Student's t-test. P-values of &#x02264;5&#x00025; were considered to indicate statistically significant differences.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Effect of oridonin on SGC-7901 cell viability</title>
<p>In order to evaluate the effect of oridonin on proliferation of the SGC-7901 cells, the cells were treated with different concentrations of oridonin for 72 h, the cell viability was quantitated by MTT assay. The results showed that oridonin inhibited the proliferation of SGC-7901 cells, and the IC<sub>50</sub> was 22.74 &#x003BC;M. The results are shown in <xref rid="tI-ijo-48-06-2453" ref-type="table">Table I</xref>.</p></sec>
<sec>
<title>Effect of oridonin on SGC-7901 cell nuclei morphology</title>
<p>The results above can significantly demonstrate that oridonin possessed notable antitumor activity on human gastric cancer SGC-7901 cells. To determine whether the antitumor activity of oridonin was due to induction of apoptosis, SGC-7901 cells were stained with Hoechst 33342 to examine the nuclear morphological changes. The results showed that cells of the control group had normal nuclear morphology and the dye of Hoechst 33342 was evenly distributed under fluorescent microscope, which indicated that the chromatin was equivalently distributed in the nucleus. However, after treatment with different concentrations of oridonin for 24 h, the characteristic features of apoptosis (including marked nuclear fragmentation, nuclear blebbing, condensation of chromatin, and emitting brighter fluorescence) was clearly detected in the SGC-7901 cells under the inverted fluorescence microscope (<xref rid="f2-ijo-48-06-2453" ref-type="fig">Fig. 2Ac&#x02013;e</xref>). These results indicated that oridonin induced cell apoptosis in human gastric carcinoma.</p></sec>
<sec>
<title>Effect of oridonin on SGC-7901 cell membrance morphology</title>
<p>In order to confirm whether oridonin induced cell apoptosis, we applied the assay of Annexin V-FITC stain for detection of phosphatidylserine (PS), the biochemical marker of apoptosis. PS is normally located in the inner plasma membrane, however, in the early apoptosis the PS is transferred to its outer surface. Annexin V-FITC combined with PS of the outer surface of the membrance and emit green fluorescent. After treatment with different concentrations of oridonin for 24 h, SGC-7901 cells were stained by Annexin V-FITC (green fluorescence) and PI (red fluorescence), and observed and photographed by laser scanning confocal microscopy. The results showed that a large number of cells treated with oridonin were positively stained by Annexin V-FITC (<xref rid="f2-ijo-48-06-2453" ref-type="fig">Fig. 2Bc&#x02013;e</xref>). Which showed that oridonin was able to induce SGC-7901 cell apoptosis.</p></sec>
<sec>
<title>Oridonin induces early apoptosis rate of SGC-7901 cells</title>
<p>To quantify the apoptotic rate of oridonin on SGC-7901 cells, the Annexin V-FITC/PI staining and flow cytometry was adopted. The data obtained showed that oridonin induced early apoptosis of SGC-7901 cells in a dose-dependent manner (<xref rid="f3-ijo-48-06-2453" ref-type="fig">Fig. 3</xref> and <xref rid="tII-ijo-48-06-2453" ref-type="table">Table II</xref>). When the cells were treated with 0, 20, 40, 80 &#x003BC;mol/l oridonin for 24 h, the average proportion of Annexin V-staining positive cells and PI-staining negative cells (early apoptotic cells) significantly increased from 1.53&#x00025;&#x000B1;0.67&#x00025; in control to 3.33&#x00025;&#x000B1;0.29, 84.80&#x00025;&#x000B1;0.82 and 96.43&#x00025;&#x000B1;0.51&#x00025;, respectively (<xref rid="tI-ijo-48-06-2453" ref-type="table">Table I</xref>). <xref rid="f3-ijo-48-06-2453" ref-type="fig">Fig. 3B</xref> shows the graphic representation of the increase in the early apoptotic cells with increase in the dose of oridonin.</p></sec>
<sec>
<title>Oridonin affects apoptosis-associated protein expression in SGC-7901 cells</title>
<p>Whether or not oridonin induced apoptosis in SGC-7901 cell through the effects of apoptosis-associated protein, western blots were adopted to examined the protein expression of mitochondrial pathway of SGC-7901 cell treated with 2, 4, 8 &#x003BC;M oridonin. The analysis results showed that all concentrations of oridonin (2, 4, 8 &#x003BC;M) resulted in a significant increase of cytochrome c (<xref rid="f4-ijo-48-06-2453" ref-type="fig">Fig. 4A</xref>) and remarkable cleavage of caspases-3 were detected compared with the control group (<xref rid="f4-ijo-48-06-2453" ref-type="fig">Fig. 4B</xref>). Mitochondrial dysfunction is regulated by Bcl-2 family proteins, thus the Bcl-2 family proteins were examined in the study. Oridonin caused a significant reduction in Bcl-2 expression whereas the expression of Bax was significantly increased, which led to decrease of Bcl-2/Bax in a concentration-dependent manner (<xref rid="f4-ijo-48-06-2453" ref-type="fig">Fig. 4C</xref>). Thus, oridonin could induce apoptosis in SGC-7901 cells with mitochondrial pathway involved.</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p><italic>Rabdosia rubescens</italic> are used in Chinese folk medicine for treatment of esophageal cancer in Taihang Mountains area of China for a long time. Research showed that oridonin was one of the most important antitumor active ingredient of <italic>Rabdosia rubescens</italic> (<xref rid="b33-ijo-48-06-2453" ref-type="bibr">33</xref>&#x02013;<xref rid="b36-ijo-48-06-2453" ref-type="bibr">36</xref>). Our previous studies showed that oridonin could arrest the cell cycle in G<sub>2</sub>/M phase in human gastric cancer SGC-7901 cells (<xref rid="b3-ijo-48-06-2453" ref-type="bibr">3</xref>). G<sub>2</sub>/M phase cell cycle arrest induced by oridonin would cause cell apoptosis, in order to confirm this hypothesis, we observed apoptotic effect of oridonin on SGC-7901 cells and the expression of apoptosis related protein, which has scarely been reported in SGC-7901 gastric cancer cells.</p>
<p>In the Hoechst 33342 assay, cells stained by Hoechst33342 were observed by fluorescence microscopy, a classic method to distinguish apoptotic cells, normal cells and necrotic cells (<xref rid="b37-ijo-48-06-2453" ref-type="bibr">37</xref>,<xref rid="b38-ijo-48-06-2453" ref-type="bibr">38</xref>). A small amount of Hoechst 33342 could penetrate the normal cell membranes and emit equivalent dark blue fluorescence after combination with DNA. However, lighter blue fluorescence was emitted in the apoptotic cells, because of membrane permeability enhancement, a large amount of Hoechst 33342 penetration, DNA breakage and function inactivation of P-glycoprotein. The fluorescence was darker in the necrotic cells than that in apoptotic cells because the structure of DNA of necrotic cells is unbroken. Thus, the fluorescence of apoptotic cells were lighter than that in the normal cells and the necrotic cells. As shown in <xref rid="f2-ijo-48-06-2453" ref-type="fig">Fig. 2Aa</xref>, cells of the control group had normal nuclear morphology under fluorescent microscope after Hoechst 33342 staining, indicating that the chromatin was equivalently distributed in the nucleus. The test group cells marked with irregular nuclei, crescent-shaped nuclei, condensation of chromatin and the morphological characteristics of apoptosis, which include emitting brighter fluorescence (<xref rid="f2-ijo-48-06-2453" ref-type="fig">Fig. 2Ac&#x02013;e</xref>), were detected after treatment with different concentrations of oridonin for 24 h. These results indicated that oridonin is capable of inducing apoptosis in SGC-7901 cells.</p>
<p>In order to further evaluate whether oridonin could induce apoptosis in SGC-7901 cells, the cells were treated with the stain of Annexin V-FITC/PI and detected by confocal microscopy. The results showed that a large number of cells treated by oridonin were positively stained by Annexin V-FITC (<xref rid="f2-ijo-48-06-2453" ref-type="fig">Fig. 2Bc&#x02013;e</xref>), which showed that oridonin could induce SGC-7901 cell apoptosis. The conclusion was consistent with that detected by Hoechst 33342 assay.</p>
<p>After qualitative research of apoptosis induced by oridonin, cells stained with Annexin V-FITC/PI were detected by flow cytometer to quantify the early apoptotic rate induced by oridonin. The percentage of live, early apoptotic, late apoptotic and dead cells were calculated. The results showed that oridonin was able to induce apoptosis of SGC-7901 cells (<xref rid="f3-ijo-48-06-2453" ref-type="fig">Fig. 3</xref> and <xref rid="tII-ijo-48-06-2453" ref-type="table">Table II</xref>), which was visible from the percentage increase in mean fluorescence intensity in the early apoptotic stages of the treated cells when compared to the control.</p>
<p>It is well known that apoptosis can be regulated by apoptotic related protein. Bcl-2 family members and caspase family members play important roles in inducing cell apoptosis. The Bcl-2 family proteins, such as the anti-apoptotic protein bcl-2 and the pro-apoptotic protein bax, could enhance the membrane permeability of the mitochondria, which results in cytochrome c release from mitochondria to the cytoplasm (<xref rid="b39-ijo-48-06-2453" ref-type="bibr">39</xref>). Cytochrome c is combined with apoptosis protease activating factor-1, recruits and cleaves procaspase-9, and activates caspase-3, which is responsible for apoptosis (<xref rid="b40-ijo-48-06-2453" ref-type="bibr">40</xref>). In order to examine the underlying mechanism of apoptosis of oridonin, the respective expression of Bcl-2, Bax, cytochrome c and cleaved caspase-3 was examined.</p>
<p>Based on the results from western blot analysis, oridonin increased the protein expression of Bax, and decreased the protein expression of Bcl-2 (<xref rid="f4-ijo-48-06-2453" ref-type="fig">Fig. 4C</xref>). The ratio of Bcl-2/Bax expression was decreased. Which led to cytochrome c release to the cytoplasm, as shown on the results (<xref rid="f4-ijo-48-06-2453" ref-type="fig">Fig. 4A</xref>) oridonin also increased the expression of cytochrome c in the cytoplasm in SGC-7901 cells. These observations suggest that oridonin induced apoptosis of SGC-7901 cells via mitochondria-dependent pathway.</p>
<p>Caspase-3, one of the family members of cysteinyl aspartate proteases, is an executioner enzyme inducing apoptosis (<xref rid="b41-ijo-48-06-2453" ref-type="bibr">41</xref>). Mitochondrial pathway (<xref rid="b42-ijo-48-06-2453" ref-type="bibr">42</xref>), death receptor-mediated pathway (<xref rid="b43-ijo-48-06-2453" ref-type="bibr">43</xref>) and endoplasmic reticulum pathway (<xref rid="b44-ijo-48-06-2453" ref-type="bibr">44</xref>) are the major signal transduction pathways that induced apoptosis (<xref rid="b45-ijo-48-06-2453" ref-type="bibr">45</xref>,<xref rid="b46-ijo-48-06-2453" ref-type="bibr">46</xref>), which ultimately induce cell apoptosis by activating caspase-3 (<xref rid="b47-ijo-48-06-2453" ref-type="bibr">47</xref>). We found that oridonin evoked caspase-3 activation, as evidenced by the appearance of 17 kDa subunits, which showed that oridonin induced SGC-7901 apoptosis was caspase-3 dependent.</p>
<p>In conclusion, the possible significant molecular signal pathways for oridonin inducing apoptosis in SGC-7901 cells is shown in <xref rid="f5-ijo-48-06-2453" ref-type="fig">Fig. 5</xref>. Oridonin may decrease the ratio of Bcl-2/Bax, which lead to dysfunction of mitochondria and cause cytochrome c release, then activate the caspase-3 leading to apoptosis. The present study demonstrated that oridonin induced apoptosis in SGC-7901 cells via the mitochondrial signal pathway, which may represent one of the major mechanisms of oridonin-mediated apoptosis in SGC-7901 cells.</p></sec></body>
<back>
<ack>
<title>Acknowledgements</title>
<p>This study was financially supported by Science and Technology Innovation Team Program in Higher Education Institutions of Heilongjiang Province (2014TD009), and the Program for New Century Excellent Talents in Heilongjiang Provincial University (1251-NCET-019), Science and Technology Research Project of Heilongjiang Province Department of Education (12541571).</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-ijo-48-06-2453"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torre</surname><given-names>LA</given-names></name><name><surname>Bray</surname><given-names>F</given-names></name><name><surname>Siegel</surname><given-names>RL</given-names></name><name><surname>Ferlay</surname><given-names>J</given-names></name><name><surname>Lortet-Tieulent</surname><given-names>J</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name></person-group><article-title>Global cancer statistics, 2012</article-title><source>CA Cancer J Clin</source><volume>65</volume><fpage>87</fpage><lpage>108</lpage><year>2015</year><pub-id pub-id-type="doi">10.3322/caac.21262</pub-id><pub-id pub-id-type="pmid">25651787</pub-id></element-citation></ref>
<ref id="b2-ijo-48-06-2453"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitzmaurice</surname><given-names>C</given-names></name><name><surname>Dicker</surname><given-names>D</given-names></name><name><surname>Pain</surname><given-names>A</given-names></name><name><surname>Hamavid</surname><given-names>H</given-names></name><name><surname>Moradi-Lakeh</surname><given-names>M</given-names></name><name><surname>MacIntyre</surname><given-names>MF</given-names></name><name><surname>Allen</surname><given-names>C</given-names></name><name><surname>Hansen</surname><given-names>G</given-names></name><name><surname>Woodbrook</surname><given-names>R</given-names></name><name><surname>Wolfe</surname><given-names>C</given-names></name><etal/></person-group><collab>Global Burden of Disease Cancer Collaboration</collab><article-title>The global burden of cancer 2013</article-title><source>JAMA Oncol</source><volume>1</volume><fpage>505</fpage><lpage>527</lpage><year>2015</year><pub-id pub-id-type="doi">10.1001/jamaoncol.2015.0735</pub-id><pub-id pub-id-type="pmid">26181261</pub-id><pub-id pub-id-type="pmcid">4500822</pub-id></element-citation></ref>
<ref id="b3-ijo-48-06-2453"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>SY</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Qu</surname><given-names>XY</given-names></name><name><surname>Zhu</surname><given-names>N</given-names></name><name><surname>Ji</surname><given-names>YB</given-names></name></person-group><article-title>Downregulation of Cdk1 and cyclinB1 expression contributes to oridonin-induced cell cycle arrest at G2/M phase and growth inhibition in SGC-7901 gastric cancer cells</article-title><source>Asian Pac J Cancer Prev</source><volume>15</volume><fpage>6437</fpage><lpage>6441</lpage><year>2014</year><pub-id pub-id-type="doi">10.7314/APJCP.2014.15.15.6437</pub-id><pub-id pub-id-type="pmid">25124639</pub-id></element-citation></ref>
<ref id="b4-ijo-48-06-2453"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>PY</given-names></name><name><surname>Zhao</surname><given-names>GX</given-names></name><name><surname>Chang</surname><given-names>LS</given-names></name></person-group><article-title>Local thermotherapy with rabdosia liquid as prophylactic measure for recurrence of superficial urinary bladder carcinoma: A non-randomized contemporary controlled study</article-title><source>Zhongguo Zhong Xi Yi Jie He Za Zhi</source><volume>25</volume><fpage>1115</fpage><lpage>1117</lpage><year>2005</year><comment>(In Chinese)</comment></element-citation></ref>
<ref id="b5-ijo-48-06-2453"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>RL</given-names></name></person-group><article-title>A report of 40 cases of esophageal carcinoma surviving for more than 5 years after treatment with drugs</article-title><source>Zhonghua Zhong Liu Za Zhi</source><volume>15</volume><fpage>300</fpage><lpage>302</lpage><year>1993</year><comment>(In Chinese)</comment><pub-id pub-id-type="pmid">8174469</pub-id></element-citation></ref>
<ref id="b6-ijo-48-06-2453"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>RL</given-names></name><name><surname>Gao</surname><given-names>BL</given-names></name><name><surname>Xiong</surname><given-names>ML</given-names></name><name><surname>Mei</surname><given-names>QD</given-names></name><name><surname>Fan</surname><given-names>KS</given-names></name><name><surname>Zuo</surname><given-names>ZK</given-names></name><name><surname>Lang</surname><given-names>TL</given-names></name><name><surname>Gao</surname><given-names>GQ</given-names></name><name><surname>Ji</surname><given-names>ZC</given-names></name><name><surname>Wei</surname><given-names>DC</given-names></name><etal/></person-group><article-title>Potentiation by Rabdosia rubescens on chemotherapy of advanced esophageal carcinoma</article-title><source>Zhonghua Zhong Liu Za Zhi</source><volume>8</volume><fpage>297</fpage><lpage>299</lpage><year>1986</year><comment>(In Chinese)</comment><pub-id pub-id-type="pmid">2428570</pub-id></element-citation></ref>
<ref id="b7-ijo-48-06-2453"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de la Taille</surname><given-names>A</given-names></name><name><surname>Hayek</surname><given-names>OR</given-names></name><name><surname>Burchardt</surname><given-names>M</given-names></name><name><surname>Burchardt</surname><given-names>T</given-names></name><name><surname>Katz</surname><given-names>AE</given-names></name></person-group><article-title>Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: Two case reports</article-title><source>J Altern Complement Med</source><volume>6</volume><fpage>449</fpage><lpage>451</lpage><year>2000</year><pub-id pub-id-type="doi">10.1089/acm.2000.6.449</pub-id><pub-id pub-id-type="pmid">11059508</pub-id></element-citation></ref>
<ref id="b8-ijo-48-06-2453"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lou</surname><given-names>H</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Zheng</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name></person-group><article-title>Oridonin nanosuspension enhances anti-tumor efficacy in SMMC-7721 cells and H22 tumor bearing mice</article-title><source>Colloids Surf B Biointerfaces</source><volume>87</volume><fpage>319</fpage><lpage>325</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.colsurfb.2011.05.037</pub-id><pub-id pub-id-type="pmid">21676599</pub-id></element-citation></ref>
<ref id="b9-ijo-48-06-2453"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Dou</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Hou</surname><given-names>G</given-names></name><etal/></person-group><article-title>The antitumor activity of the novel compound jesridonin on human esophageal carcinoma cells</article-title><source>PLoS One</source><volume>10</volume><fpage>e0130284</fpage><year>2015</year><pub-id pub-id-type="doi">10.1371/journal.pone.0130284</pub-id><pub-id pub-id-type="pmid">26103161</pub-id><pub-id pub-id-type="pmcid">4477902</pub-id></element-citation></ref>
<ref id="b10-ijo-48-06-2453"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Jia</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Hao</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><etal/></person-group><article-title>Synthesis, characterization, in vitro and in vivo evaluation of PEGylated oridonin conjugates</article-title><source>Int J Pharm</source><volume>456</volume><fpage>80</fpage><lpage>86</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.ijpharm.2013.08.014</pub-id><pub-id pub-id-type="pmid">23973480</pub-id></element-citation></ref>
<ref id="b11-ijo-48-06-2453"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>GB</given-names></name><name><surname>Kang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>FX</given-names></name><name><surname>Weng</surname><given-names>XQ</given-names></name><name><surname>Shen</surname><given-names>ZX</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo</article-title><source>Blood</source><volume>109</volume><fpage>3441</fpage><lpage>3450</lpage><year>2007</year><pub-id pub-id-type="doi">10.1182/blood-2006-06-032250</pub-id><pub-id pub-id-type="pmid">17197433</pub-id><pub-id pub-id-type="pmcid">1852250</pub-id></element-citation></ref>
<ref id="b12-ijo-48-06-2453"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lou</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Feng</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name></person-group><article-title>In vitro and in vivo antitumor activity of oridonin nanosuspension</article-title><source>Int J Pharm</source><volume>379</volume><fpage>181</fpage><lpage>186</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.ijpharm.2009.06.022</pub-id><pub-id pub-id-type="pmid">19563872</pub-id></element-citation></ref>
<ref id="b13-ijo-48-06-2453"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>CJ</given-names></name><name><surname>Zhu</surname><given-names>GJ</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Shi</surname><given-names>BH</given-names></name></person-group><article-title>Preparation, in vitro, and in vivo antitumor activity of folate receptor-targeted nanoliposomes containing oridonin</article-title><source>Drug Dev Res</source><volume>74</volume><fpage>43</fpage><lpage>49</lpage><year>2013</year><pub-id pub-id-type="doi">10.1002/ddr.21055</pub-id></element-citation></ref>
<ref id="b14-ijo-48-06-2453"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>LH</given-names></name><name><surname>Li</surname><given-names>WJ</given-names></name><name><surname>Jiang</surname><given-names>XQ</given-names></name><name><surname>Chen</surname><given-names>YL</given-names></name><name><surname>Tao</surname><given-names>SX</given-names></name><name><surname>Qian</surname><given-names>WL</given-names></name><name><surname>He</surname><given-names>JS</given-names></name></person-group><article-title>Study on the autophagy of prostate cancer PC-3 cells induced by oridonin</article-title><source>Anat Rec (Hoboken)</source><volume>295</volume><fpage>417</fpage><lpage>422</lpage><year>2012</year><pub-id pub-id-type="doi">10.1002/ar.21528</pub-id></element-citation></ref>
<ref id="b15-ijo-48-06-2453"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>YC</given-names></name><name><surname>Wang</surname><given-names>HJ</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>WW</given-names></name><name><surname>Liu</surname><given-names>BB</given-names></name><name><surname>Tashiro</surname><given-names>S</given-names></name><name><surname>Onodera</surname><given-names>S</given-names></name><name><surname>Ikejima</surname><given-names>T</given-names></name></person-group><article-title>Oridonin induces apoptosis and autophagy in murine fibrosarcoma L929 cells partly via NO-ERK-p53 positive-feedback loop signaling pathway</article-title><source>Acta Pharmacol Sin</source><volume>33</volume><fpage>1055</fpage><lpage>1061</lpage><year>2012</year><pub-id pub-id-type="doi">10.1038/aps.2012.53</pub-id><pub-id pub-id-type="pmid">22842735</pub-id><pub-id pub-id-type="pmcid">4085664</pub-id></element-citation></ref>
<ref id="b16-ijo-48-06-2453"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Fan</surname><given-names>SM</given-names></name><name><surname>Song</surname><given-names>JK</given-names></name><name><surname>Tashiro</surname><given-names>S</given-names></name><name><surname>Onodera</surname><given-names>S</given-names></name><name><surname>Ikejima</surname><given-names>T</given-names></name></person-group><article-title>Hydroxyl radical (&#x000B7;OH) played a pivotal role in oridonin-induced apoptosis and autophagy in human epidermoid carcinoma A431 cells</article-title><source>Biol Pharm Bull</source><volume>35</volume><fpage>2148</fpage><lpage>2159</lpage><year>2012</year><pub-id pub-id-type="doi">10.1248/bpb.b12-00405</pub-id></element-citation></ref>
<ref id="b17-ijo-48-06-2453"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zang</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>H</given-names></name><name><surname>Ye</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Fan</surname><given-names>S</given-names></name><name><surname>Tashiro</surname><given-names>S</given-names></name><name><surname>Onodera</surname><given-names>S</given-names></name><name><surname>Ikejima</surname><given-names>T</given-names></name></person-group><article-title>Nitric oxide augments oridonin-induced efferocytosis by human histocytic lymphoma U937 cells via autophagy and the NF-&#x003BA;B-COX-2-IL-1&#x003B2; pathway</article-title><source>Free Radic Res</source><volume>46</volume><fpage>1207</fpage><lpage>1219</lpage><year>2012</year><pub-id pub-id-type="doi">10.3109/10715762.2012.700515</pub-id><pub-id pub-id-type="pmid">22670565</pub-id></element-citation></ref>
<ref id="b18-ijo-48-06-2453"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>JH</given-names></name><name><surname>Chai</surname><given-names>K</given-names></name><name><surname>Tashiro</surname><given-names>S</given-names></name><name><surname>Onodera</surname><given-names>S</given-names></name><name><surname>Ikejima</surname><given-names>T</given-names></name></person-group><article-title>Inhibition of c-Met promoted apoptosis, autophagy and loss of the mitochondrial transmembrane potential in oridonin-induced A549 lung cancer cells</article-title><source>J Pharm Pharmacol</source><volume>65</volume><fpage>1622</fpage><lpage>1642</lpage><year>2013</year><pub-id pub-id-type="doi">10.1111/jphp.12140</pub-id><pub-id pub-id-type="pmid">24102522</pub-id></element-citation></ref>
<ref id="b19-ijo-48-06-2453"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>TC</given-names></name><name><surname>Wijeratne</surname><given-names>EK</given-names></name><name><surname>Liang</surname><given-names>JY</given-names></name><name><surname>Gunatilaka</surname><given-names>AL</given-names></name><name><surname>Wu</surname><given-names>JM</given-names></name></person-group><article-title>Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens</article-title><source>Biochem Biophys Res Commun</source><volume>337</volume><fpage>224</fpage><lpage>231</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/j.bbrc.2005.09.040</pub-id><pub-id pub-id-type="pmid">16176802</pub-id></element-citation></ref>
<ref id="b20-ijo-48-06-2453"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Tan</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name></person-group><article-title>DNA damage induced by oridonin involves cell cycle arrest at G2/M phase in human MCF-7 cells</article-title><source>Contemp Oncol (Pozn)</source><volume>17</volume><fpage>38</fpage><lpage>44</lpage><year>2013</year></element-citation></ref>
<ref id="b21-ijo-48-06-2453"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Ye</surname><given-names>Y</given-names></name><name><surname>Chui</surname><given-names>JH</given-names></name><name><surname>Zhu</surname><given-names>GY</given-names></name><name><surname>Li</surname><given-names>YW</given-names></name><name><surname>Fong</surname><given-names>DWF</given-names></name><name><surname>Yu</surname><given-names>ZL</given-names></name></person-group><article-title>Oridonin induces G2/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells</article-title><source>Oncol Rep</source><volume>24</volume><fpage>647</fpage><lpage>651</lpage><year>2010</year><pub-id pub-id-type="pmid">20664969</pub-id></element-citation></ref>
<ref id="b22-ijo-48-06-2453"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Feng</surname><given-names>F</given-names></name><name><surname>Ren</surname><given-names>G</given-names></name><name><surname>Chu</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Tian</surname><given-names>K</given-names></name></person-group><article-title>Oridonin nanosuspension was more effective than free oridonin on G2/M cell cycle arrest and apoptosis in the human pancreatic cancer PANC-1 cell line</article-title><source>Int J Nanomed</source><volume>7</volume><fpage>1793</fpage><lpage>1804</lpage><year>2012</year></element-citation></ref>
<ref id="b23-ijo-48-06-2453"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Qiu</surname><given-names>F</given-names></name><name><surname>Ye</surname><given-names>YC</given-names></name><name><surname>Tashiro</surname><given-names>S</given-names></name><name><surname>Onodera</surname><given-names>S</given-names></name><name><surname>Ikejima</surname><given-names>T</given-names></name></person-group><article-title>Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells</article-title><source>Arch Biochem Biophys</source><volume>490</volume><fpage>70</fpage><lpage>75</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.abb.2009.08.011</pub-id><pub-id pub-id-type="pmid">19699177</pub-id></element-citation></ref>
<ref id="b24-ijo-48-06-2453"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>JH</given-names></name><name><surname>Qiu</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Tashiro</surname><given-names>S</given-names></name><name><surname>Onodera</surname><given-names>S</given-names></name><name><surname>Ikejima</surname><given-names>T</given-names></name></person-group><article-title>Induction of G(2)/M phase arrest and apoptosis by oridonin in human laryngeal carcinoma cells</article-title><source>J Nat Prod</source><volume>73</volume><fpage>1058</fpage><lpage>1063</lpage><year>2010</year><pub-id pub-id-type="doi">10.1021/np9008199</pub-id><pub-id pub-id-type="pmid">20496901</pub-id></element-citation></ref>
<ref id="b25-ijo-48-06-2453"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>N</given-names></name><name><surname>Cao</surname><given-names>SJ</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>H</given-names></name><name><surname>Tashiro</surname><given-names>S</given-names></name><name><surname>Onodera</surname><given-names>S</given-names></name><name><surname>Qiu</surname><given-names>F</given-names></name><name><surname>Ikejima</surname><given-names>T</given-names></name></person-group><article-title>Inhibition of caspase-9 by oridonin, a diterpenoid isolated from Rabdosia rubescens, augments apoptosis in human laryngeal cancer cells</article-title><source>Int J Oncol</source><volume>47</volume><fpage>2045</fpage><lpage>2056</lpage><year>2015</year><pub-id pub-id-type="pmid">26648189</pub-id><pub-id pub-id-type="pmcid">4665153</pub-id></element-citation></ref>
<ref id="b26-ijo-48-06-2453"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pi</surname><given-names>J</given-names></name><name><surname>Cai</surname><given-names>H</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>A</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Su</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>P</given-names></name><etal/></person-group><article-title>Qualitative and quantitative analysis of ROS-mediated oridonin-induced oesophageal cancer KYSE-150 cell apoptosis by atomic force microscopy</article-title><source>PLoS One</source><volume>10</volume><fpage>e0140935</fpage><year>2015</year><pub-id pub-id-type="doi">10.1371/journal.pone.0140935</pub-id><pub-id pub-id-type="pmid">26496199</pub-id><pub-id pub-id-type="pmcid">4619704</pub-id></element-citation></ref>
<ref id="b27-ijo-48-06-2453"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>D</given-names></name><name><surname>Qiu</surname><given-names>G</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Xiao</surname><given-names>B</given-names></name></person-group><article-title>Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects</article-title><source>Biomed Pharmacother</source><volume>72</volume><fpage>125</fpage><lpage>134</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.biopha.2015.04.016</pub-id><pub-id pub-id-type="pmid">26054686</pub-id></element-citation></ref>
<ref id="b28-ijo-48-06-2453"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bu</surname><given-names>HQ</given-names></name><name><surname>Liu</surname><given-names>DL</given-names></name><name><surname>Wei</surname><given-names>WT</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Cui</surname><given-names>JH</given-names></name></person-group><article-title>Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK</article-title><source>Oncol Rep</source><volume>31</volume><fpage>975</fpage><lpage>982</lpage><year>2014</year></element-citation></ref>
<ref id="b29-ijo-48-06-2453"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>DT</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name><name><surname>Xiong</surname><given-names>QX</given-names></name><name><surname>Liu</surname><given-names>WG</given-names></name><name><surname>Gao</surname><given-names>ZG</given-names></name><name><surname>Gu</surname><given-names>GX</given-names></name><name><surname>Qiu</surname><given-names>YH</given-names></name></person-group><article-title>ER stress and ASK1-JNK activation contribute to oridonin-induced apoptosis and growth inhibition in cultured human hepatoblastoma HuH-6 cells</article-title><source>Mol Cell Biochem</source><volume>379</volume><fpage>161</fpage><lpage>169</lpage><year>2013</year><pub-id pub-id-type="doi">10.1007/s11010-013-1638-2</pub-id><pub-id pub-id-type="pmid">23580093</pub-id></element-citation></ref>
<ref id="b30-ijo-48-06-2453"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Hong</surname><given-names>D</given-names></name><name><surname>Bao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Pan</surname><given-names>W</given-names></name></person-group><article-title>Oridonin induces the apoptosis of metastatic hepatocellular carcinoma cells via a mitochondrial pathway</article-title><source>Oncol Lett</source><volume>6</volume><fpage>1502</fpage><lpage>1506</lpage><year>2013</year><pub-id pub-id-type="pmid">24179549</pub-id><pub-id pub-id-type="pmcid">3813803</pub-id></element-citation></ref>
<ref id="b31-ijo-48-06-2453"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsia</surname><given-names>TC</given-names></name><name><surname>Yu</surname><given-names>CC</given-names></name><name><surname>Hsu</surname><given-names>SC</given-names></name><name><surname>Tang</surname><given-names>NY</given-names></name><name><surname>Lu</surname><given-names>HF</given-names></name><name><surname>Huang</surname><given-names>YP</given-names></name><name><surname>Wu</surname><given-names>SH</given-names></name><name><surname>Lin</surname><given-names>JG</given-names></name><name><surname>Chung</surname><given-names>JG</given-names></name></person-group><article-title>Cantharidin induces apoptosis of H460 human lung cancer cells through mitochondria-dependent pathways</article-title><source>Int J Oncol</source><volume>45</volume><fpage>245</fpage><lpage>254</lpage><year>2014</year><pub-id pub-id-type="pmid">24818581</pub-id></element-citation></ref>
<ref id="b32-ijo-48-06-2453"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradford</surname><given-names>MM</given-names></name></person-group><article-title>A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</article-title><source>Anal Biochem</source><volume>72</volume><fpage>248</fpage><lpage>254</lpage><year>1976</year><pub-id pub-id-type="doi">10.1016/0003-2697(76)90527-3</pub-id><pub-id pub-id-type="pmid">942051</pub-id></element-citation></ref>
<ref id="b33-ijo-48-06-2453"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meade-Tollin</surname><given-names>LC</given-names></name><name><surname>Wijeratne</surname><given-names>EMK</given-names></name><name><surname>Cooper</surname><given-names>D</given-names></name><name><surname>Guild</surname><given-names>M</given-names></name><name><surname>Jon</surname><given-names>E</given-names></name><name><surname>Fritz</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>GX</given-names></name><name><surname>Whitesell</surname><given-names>L</given-names></name><name><surname>Liang</surname><given-names>JY</given-names></name><name><surname>Gunatilaka</surname><given-names>AAL</given-names></name></person-group><article-title>Ponicidin and oridonin are responsible for the antiangiogenic activity of Rabdosia rubescens, a constituent of the herbal supplement PC SPES</article-title><source>J Nat Prod</source><volume>67</volume><fpage>2</fpage><lpage>4</lpage><year>2004</year><pub-id pub-id-type="doi">10.1021/np0304114</pub-id><pub-id pub-id-type="pmid">14738375</pub-id></element-citation></ref>
<ref id="b34-ijo-48-06-2453"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>AM</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Kesler</surname><given-names>K</given-names></name><name><surname>Deng</surname><given-names>M</given-names></name><name><surname>Burhenn</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Moro</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Heber</surname><given-names>D</given-names></name></person-group><article-title>Genomic and in vivo evidence of synergy of a herbal extract compared to its most active ingredient: Rabdosia rubescens vs</article-title><source>oridonin Exp Ther Med</source><volume>1</volume><fpage>1013</fpage><lpage>1017</lpage><year>2010</year></element-citation></ref>
<ref id="b35-ijo-48-06-2453"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikezoe</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Bandobashi</surname><given-names>K</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name><name><surname>Takemoto</surname><given-names>S</given-names></name><name><surname>Machida</surname><given-names>H</given-names></name><name><surname>Togitani</surname><given-names>K</given-names></name><name><surname>Koeffler</surname><given-names>HP</given-names></name><name><surname>Taguchi</surname><given-names>H</given-names></name></person-group><article-title>Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways</article-title><source>Mol Cancer Ther</source><volume>4</volume><fpage>578</fpage><lpage>586</lpage><year>2005</year><pub-id pub-id-type="doi">10.1158/1535-7163.MCT-04-0277</pub-id><pub-id pub-id-type="pmid">15827331</pub-id></element-citation></ref>
<ref id="b36-ijo-48-06-2453"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Halicka</surname><given-names>HD</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Traganos</surname><given-names>F</given-names></name><name><surname>Darzynkiewicz</surname><given-names>Z</given-names></name></person-group><article-title>The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage</article-title><source>Int J Oncol</source><volume>26</volume><fpage>579</fpage><lpage>588</lpage><year>2005</year><pub-id pub-id-type="pmid">15703811</pub-id></element-citation></ref>
<ref id="b37-ijo-48-06-2453"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Kwak</surname><given-names>JH</given-names></name><name><surname>Pyo</surname><given-names>S</given-names></name></person-group><article-title>Different anticancer effects of Saxifragifolin A on estrogen receptor-positive and estrogen receptor-negative breast cancer cells</article-title><source>Phytomedicine</source><volume>22</volume><fpage>820</fpage><lpage>828</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.phymed.2015.05.057</pub-id><pub-id pub-id-type="pmid">26220629</pub-id></element-citation></ref>
<ref id="b38-ijo-48-06-2453"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krajarng</surname><given-names>A</given-names></name><name><surname>Imoto</surname><given-names>M</given-names></name><name><surname>Tashiro</surname><given-names>E</given-names></name><name><surname>Fujimaki</surname><given-names>T</given-names></name><name><surname>Shinjo</surname><given-names>S</given-names></name><name><surname>Watanapokasin</surname><given-names>R</given-names></name></person-group><article-title>Apoptosis induction associated with the ER stress response through up-regulation of JNK in HeLa cells by gambogic acid</article-title><source>BMC Complement Altern Med</source><volume>15</volume><fpage>26</fpage><year>2015</year><pub-id pub-id-type="doi">10.1186/s12906-015-0544-4</pub-id><pub-id pub-id-type="pmid">25887496</pub-id><pub-id pub-id-type="pmcid">4340837</pub-id></element-citation></ref>
<ref id="b39-ijo-48-06-2453"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>An</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Yin</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zou</surname><given-names>C</given-names></name><name><surname>Wei</surname><given-names>B</given-names></name><name><surname>Lv</surname><given-names>R</given-names></name><etal/></person-group><article-title>Neuregulin-1 protects against doxorubicin-induced apoptosis in cardiomyocytes through an Akt-dependent pathway</article-title><source>Physiol Res</source><volume>62</volume><fpage>379</fpage><lpage>385</lpage><year>2013</year><pub-id pub-id-type="pmid">23590603</pub-id></element-citation></ref>
<ref id="b40-ijo-48-06-2453"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishida</surname><given-names>K</given-names></name><name><surname>Yamaguchi</surname><given-names>O</given-names></name><name><surname>Otsu</surname><given-names>K</given-names></name></person-group><article-title>Crosstalk between autophagy and apoptosis in heart disease</article-title><source>Circ Res</source><volume>103</volume><fpage>343</fpage><lpage>351</lpage><year>2008</year><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.175448</pub-id><pub-id pub-id-type="pmid">18703786</pub-id></element-citation></ref>
<ref id="b41-ijo-48-06-2453"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazur</surname><given-names>AJ</given-names></name><name><surname>Nowak</surname><given-names>D</given-names></name><name><surname>Mannherz</surname><given-names>HG</given-names></name><name><surname>Malicka-B&#x00142;aszkiewicz</surname><given-names>M</given-names></name></person-group><article-title>Methotrexate induces apoptosis in CaSki and NRK cells and influences the organization of their actin cytoskeleton</article-title><source>Eur J Pharmacol</source><volume>613</volume><fpage>24</fpage><lpage>33</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.ejphar.2009.04.020</pub-id><pub-id pub-id-type="pmid">19383496</pub-id></element-citation></ref>
<ref id="b42-ijo-48-06-2453"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Yedjou</surname><given-names>CG</given-names></name><name><surname>Tchounwou</surname><given-names>PB</given-names></name></person-group><article-title>Arsenic trioxide induces oxidative stress, DNA damage, and mitochondrial pathway of apoptosis in human leukemia (HL-60) cells</article-title><source>J Exp Clin Cancer Res</source><volume>33</volume><fpage>42</fpage><year>2014</year><pub-id pub-id-type="doi">10.1186/1756-9966-33-42</pub-id><pub-id pub-id-type="pmid">24887205</pub-id><pub-id pub-id-type="pmcid">4049373</pub-id></element-citation></ref>
<ref id="b43-ijo-48-06-2453"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>CL</given-names></name><name><surname>Wen</surname><given-names>Q</given-names></name><name><surname>Fan</surname><given-names>TJ</given-names></name></person-group><article-title>Cytotoxicity of atropine to human corneal epithelial cells by inducing cell cycle arrest and mitochondrion-dependent apoptosis</article-title><source>Exp Toxicol Pathol</source><volume>67</volume><fpage>517</fpage><lpage>524</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.etp.2015.07.006</pub-id><pub-id pub-id-type="pmid">26296992</pub-id></element-citation></ref>
<ref id="b44-ijo-48-06-2453"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broecker-Preuss</surname><given-names>M</given-names></name><name><surname>Viehof</surname><given-names>J</given-names></name><name><surname>Jastrow</surname><given-names>H</given-names></name><name><surname>Becher-Boveleth</surname><given-names>N</given-names></name><name><surname>Fuhrer</surname><given-names>D</given-names></name><name><surname>Mann</surname><given-names>K</given-names></name></person-group><article-title>Cell death induction by the BH3 mimetic GX15-070 in thyroid carcinoma cells</article-title><source>J Exp Clin Cancer Res</source><volume>34</volume><fpage>69</fpage><year>2015</year><pub-id pub-id-type="doi">10.1186/s13046-015-0186-x</pub-id><pub-id pub-id-type="pmid">26198850</pub-id><pub-id pub-id-type="pmcid">4510903</pub-id></element-citation></ref>
<ref id="b45-ijo-48-06-2453"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fulda</surname><given-names>S</given-names></name></person-group><article-title>Caspase-8 in cancer biology and therapy</article-title><source>Cancer Lett</source><volume>281</volume><fpage>128</fpage><lpage>133</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.canlet.2008.11.023</pub-id></element-citation></ref>
<ref id="b46-ijo-48-06-2453"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danial</surname><given-names>NN</given-names></name><name><surname>Korsmeyer</surname><given-names>SJ</given-names></name></person-group><article-title>Cell death: Critical control points</article-title><source>Cell</source><volume>116</volume><fpage>205</fpage><lpage>219</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/S0092-8674(04)00046-7</pub-id><pub-id pub-id-type="pmid">14744432</pub-id></element-citation></ref>
<ref id="b47-ijo-48-06-2453"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>C</given-names></name><name><surname>Luo</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Gu</surname><given-names>C</given-names></name><name><surname>Zu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Efferth</surname><given-names>T</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name></person-group><article-title>Aspidin PB, a phloroglucinol derivative, induces apoptosis in human hepatocarcinoma HepG2 cells by modulating PI3K/Akt/GSK3&#x003B2; pathway</article-title><source>Chem Biol Interact</source><volume>201</volume><fpage>1</fpage><lpage>8</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.cbi.2012.11.005</pub-id></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-ijo-48-06-2453" position="float">
<label>Figure 1</label>
<caption>
<p>Structure of oridonin.</p></caption>
<graphic xlink:href="IJO-48-06-2453-g00.gif"/></fig>
<fig id="f2-ijo-48-06-2453" position="float">
<label>Figure 2</label>
<caption>
<p>(A) The morphology of SGC-7901 cells exposed to oridonin for 24 h was observed under an inverted fluorescence microscope. Cells were treated with 0.1&#x00025; DMSO (a), 18 &#x003BC;mol/l hydroxycamptothecin (b), 10 &#x003BC;M oridonin (c), 20 &#x003BC;M oridonin (d) and 40 &#x003BC;M oridonin (e) for 24 h, respectively (x400 magnification). (B) Detection of externalized phosphatidylserine by Annexin V-FITC in SGC-7901 cells after oridonin treatment for 24 h. (a) Control, (b) 7 &#x003BC;M doxorubicin, (c) 10 &#x003BC;M oridonin, (d) 20 &#x003BC;M oridonin, (e) 40 &#x003BC;M oridonin; first column represent cells stained with Annexin V-FITC. Second column represent cells stained with PI. Third column show fluorescence of Annexin V-FITC merged with PI staining. Control cells were treated with 0.1&#x00025; DMSO, and the cells were treated with 0.1&#x00025; DMSO and oridonin.</p></caption>
<graphic xlink:href="IJO-48-06-2453-g01.gif"/></fig>
<fig id="f3-ijo-48-06-2453" position="float">
<label>Figure 3</label>
<caption>
<p>Oridonin-induced apoptosis in SGC-7901 cells using Annexin V-FITC/PI and flow cytometry. (A) Flow cytometric scatter diagram. Cell were treated with different concentrations of oridonin for 24 h. (a) Control; (b) treated with 7 &#x003BC;M doxorubicin; (c) treated with 10 &#x003BC;M oridonin; (d) treated with 20 &#x003BC;M oridonin; (e) treated with 40 &#x003BC;M oridonin. (B) Columns show the mean values of three experiments (mean &#x000B1; SD). <sup>**</sup>P&lt;0.01, P-value compared with the control group.</p></caption>
<graphic xlink:href="IJO-48-06-2453-g02.gif"/></fig>
<fig id="f4-ijo-48-06-2453" position="float">
<label>Figure 4</label>
<caption>
<p>Effect of oridonin on apoptosis-related protein expression in SGC-7901 cells. SGC-7901 cells were treated with 2, 4, 8 &#x003BC;M of oridonin for 24 h and then total proteins were quantitated and apoptosis-associated proteins were examined by western blot analysis as described in Materials and methods. (A) Cytochrome c, (B) caspase-3 and cleaved-caspase-3, (C) Bcl-2 and Bax. <sup>**</sup>P&lt;0.01 compare with control group.</p></caption>
<graphic xlink:href="IJO-48-06-2453-g03.gif"/></fig>
<fig id="f5-ijo-48-06-2453" position="float">
<label>Figure 5</label>
<caption>
<p>The possible signaling pathways for oridonin-induced apoptosis in SGC-7901 cells.</p></caption>
<graphic xlink:href="IJO-48-06-2453-g04.gif"/></fig>
<table-wrap id="tI-ijo-48-06-2453" position="float">
<label>Table I</label>
<caption>
<p>Doses inducing 50&#x00025; cell growth inhibition (IC<sub>50</sub>) of oridonin against human gastric cancer SGC-7901 cells.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="bottom" align="left">Groups</th>
<th valign="bottom" align="center">IC<sub>50</sub> (&#x003BC;M)</th></tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Oridonin</td>
<td valign="top" align="center">22.74</td></tr>
<tr>
<td valign="top" align="left">Hydroxycamptothecin</td>
<td valign="top" align="center">17.46</td></tr></tbody></table></table-wrap>
<table-wrap id="tII-ijo-48-06-2453" position="float">
<label>Table II</label>
<caption>
<p>Oridonin-induced cell apoptotic rate on SGC-7901 cells.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="bottom" align="left">Group</th>
<th valign="bottom" align="center">Dosage (&#x003BC;M)</th>
<th valign="bottom" align="center">Early apoptotic rate (&#x00025;)</th>
<th valign="bottom" align="center">Late apoptotic rate (&#x00025;)</th></tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Control</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">1.53&#x000B1;0.67</td>
<td valign="top" align="center">0.70&#x000B1;0.20</td></tr>
<tr>
<td valign="top" align="left">Doxorubicin</td>
<td valign="top" align="center">7</td>
<td valign="top" align="center">32.33&#x000B1;1.68<xref rid="tfn2-ijo-48-06-2453" ref-type="table-fn">b</xref></td>
<td valign="top" align="center">27.60&#x000B1;2.65<xref rid="tfn2-ijo-48-06-2453" ref-type="table-fn">b</xref></td></tr>
<tr>
<td valign="top" align="left">Oridonin</td>
<td valign="top" align="center">20</td>
<td valign="top" align="center">3.33&#x000B1;0.29</td>
<td valign="top" align="center">0.73&#x000B1;0.12</td></tr>
<tr>
<td valign="top" align="left">Oridonin</td>
<td valign="top" align="center">40</td>
<td valign="top" align="center">84.80&#x000B1;0.82<xref rid="tfn2-ijo-48-06-2453" ref-type="table-fn">b</xref></td>
<td valign="top" align="center">4.83&#x000B1;0.25</td></tr>
<tr>
<td valign="top" align="left">Oridonin</td>
<td valign="top" align="center">80</td>
<td valign="top" align="center">96.43&#x000B1;0.51<xref rid="tfn2-ijo-48-06-2453" ref-type="table-fn">b</xref></td>
<td valign="top" align="center">2.13&#x000B1;0.47</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn1-ijo-48-06-2453">
<label>a</label>
<p>P&lt;0.05,</p></fn><fn id="tfn2-ijo-48-06-2453">
<label>b</label>
<p>P&lt;0.01 vs. control.</p></fn></table-wrap-foot></table-wrap></floats-group></article>
